一个药物筛选大项目面临断奶,可以看出美国的经济情况正在影响这一些科研项目。 原文见: NATIONAL INSTITUTES OF HEALTH Drug-Screening Program Looking for a Home Jocelyn Kaiser http://www.sciencemag.org/content/334/6054/299.full
两周前的更新,看上去有很多实际应用的例子,值得参加。 计算机辅助药物设计是个很重要的领域,是新药研发中的一项重要技术。不过,作为一个学科,它的发展面临很多问题,也就是说近年来很少看到新进展,因此大家的注意力都放在应用上了。也许这次会议上能听到一些新的思路。 我前后一共参加过三次这方面(CADD)的会议,遗憾的是没有见到过一个来自国内的代表。国内那么多相关的研究人员对这么重要廉价的会议竟然无动于衷,有点不可思议。 附:会议信息 Gordon Research Conference Computer Aided Drug Design (CADD) The Impact of Computational Sciences along the Drug Discovery Process http://www.grc.org/programs.aspx?year=2011program=cadd July 17-22, 2011 Mount Snow Resort West Dover, VT SUNDAY 2:00 pm - 9:00 pm Arrival and Check-in (Office Closed 6:00 pm - 7:00 pm) 6:00 pm Dinner 7:30 pm - 7:45 pm Introductory Comments by GRC Site Staff / Welcome by the GRC Conference Chair 7:45 pm - 9:30 pm Case Studies in Drug Design I: Elaborating Fragments Discussion Leader: Catherine E. Peishoff (GSK, Collegeville, PA, USA) 7:45 pm - 8:00 pm Introduction by the discussion leader 8:00 pm - 8:30 pm Nicolas Foloppe (Vernalis, Cambridge, UK) Structure-based Discovery and Elaboration of Inhibitors of the Chk1 Kinase: From Fragment to a Candidate Series 8:30 pm - 8:45 pm Discussion 8:45 pm - 9:15 pm Gianni Chessari (Astex, Cambridge, UK) Progression of Fragment Hits into Lead Molecules 9:15 pm - 9:30 pm Discussion MONDAY 7:30 am - 8:30 am Breakfast 9:00 am - 12:30 pm Case Studies in Drug Design II: What Works, What Doesn't? Discussion Leader: Catherine E. Peishoff (GSK, Collegeville, PA, USA) 9:00 am - 9:25 am Georgia McGaughey (Merck, West Point, USA) Conformational Studies of Small Molecules and Applications to Lead Optimization 9:25 am - 9:35 am Discussion 9:35 am - 10:00 am Veer Shanmugasundaram (Pfizer, Groton, USA) A Tale of Two Receptors - On AR, ER and Targeting Switches in NHRs 10:00 am - 10:10 am Discussion 10:10 am - 10:40 am Coffee Break 10:40 am - 11:05 am Pascal Furet (Novartis, Basel, Switzerland) Structure-based Design of a New Class of Potent Non Peptide Inhibitors of the p53-MDM2 Interaction 11:05 am - 11:15 am Discussion 11:15 am - 11:40 am Kaushik Raha (GSK, Collegeville, USA) Structure-based Design of a Potent Inhibitor of Pi3K Alpha 11:40 am - 11:50 am Discussion 11:50 am - 12:15 pm Tara Mirzadegan (Johnson Johnson, San Diego, USA) Computer-Aided Drug Discovery of HIF Prolyl Hydroxylase Inhibitors for the Treatment of Anemia 12:15 pm - 12:30 pm Discussion 12:30 pm Lunch 1:30 pm - 4:00 pm Free Time 4:00 pm - 6:00 pm Poster Session I 6:00 pm Dinner 7:30 pm - 9:30 pm Prediction of ADMET Properties I Discussion Leader: Pat Walters (Vertex, Cambridge, USA) 7:30 pm - 7:40 pm Introduction by the discussion leader 7:40 pm - 8:20 pm Nigel Greene (Pfizer, Groton, USA) Combining Physicochemical Properties and In Vitro Assays to Predict In Vivo Outcomes 8:20 pm - 8:35 pm Discussion 8:35 pm - 9:15 pm Holger Fischer (Roche, Basel, Switzerland) Designing Drug Like Molecules: Impact of a Holistic Data Analysis Approach in Drug Discovery 9:15 pm - 9:30 pm Discussion TUESDAY 7:30 am - 8:30 am Breakfast 9:00 am - 12:30 pm The State of the Art of Calculating Protein-Ligand Interactions Discussion Leader: Ajay Jain (UCSF, San Francisco, USA) 9:00 am - 9:15 am Introduction by the discussion leader 9:15 am - 9:55 am Neil Taylor (Desert Scientific, Sydney, Australia) An Exploration of Network Hotspots and Cooperativity in Protein-Ligand Recognition 9:55 am - 10:10 am Discussion 10:10 am - 10:40 am Coffee Break 10:40 am - 11:20 am Jonathan Essex (University of Southampton, UK) Rigorous Free Energy Calculations in Drug Discovery: What Can they Really Do? 11:20 am - 11:35 am Discussion 11:35 am - 12:15 pm Demetri Moustakas (AstraZeneca, Wilmington, DE, USA) Towards a Single-point Estimate of the Binding Free Energy 12:15 pm - 12:30 pm Discussion 12:30 pm Lunch 1:30 pm - 6:00 pm Free Time 6:00 pm Dinner 7:30 pm - 9:30 pm Prediction of ADMET Properties II Discussion Leader: Pat Walters (Vertex, Cambridge, USA) 7:30 pm - 8:10 pm Chihae Yang (Altamira LLC, Columbus, OH, USA) Leveraging the Past to Jump Start the Future: Using a Computational Battery of Methods for Toxicity Assessment 8:10 pm - 8:30 pm Discussion 8:30 pm - 9:10 pm Scott Boyer (AstraZeneca, Gothenburg, Sweden) The Reality of Using Computational Tools to Reduce Safety Risk 9:10 pm - 9:30 pm Discussion WEDNESDAY 7:30 am - 8:30 am Breakfast 9:00 am - 11:30 am New Structures, New Insights: G Protein-Coupled Receptors Discussion Leader: Brian Shoichet (UCSF, San Francisco, USA) 9:00 am - 9:10 am Introduction by the discussion leader 9:10 am - 9:50 am Gebhard Schertler (Paul-Scherrer-Institute, Switzerland) Structure of Inactive and Active G Protein-Coupled Receptors: Implication for Activation and Ligand Binding 9:50 am - 10:05 am Discussion 10:05 am - 10:35 am Coffee Break 10:35 am - 11:15 am Stefano Costanzi (NIH, Bethesda, USA) G Protein-Coupled Receptors: Structural Modeling and Computer-Aided Ligand Discovery 11:15 am - 11:30 am Discussion 11:30 am - 12:30 pm Open Mic Session Discussion Leader: Daniel Ortwine (Genentech, South San Francisco, USA) ( 5 minute talks by poster presenters ) 12:30 pm Lunch 1:30 pm - 4:00 pm Free Time 4:00 pm - 6:00 pm Poster Session II 6:00 pm Dinner 7:00 pm - 7:30 pm Business Meeting Nominations for the next Vice Chair; Fill out Conference Evaluation Forms; Discuss future Site Scheduling preferences; Election of the next Vice Chair 7:30 pm - 9:30 pm Prediction of Small Molecule Crystal Structures Discussion Leader: Georgia McGaughey (Merck, West Point, USA) 7:30 pm - 7:40 pm Introduction by the discussion leader 7:40 pm - 8:20 pm Marcus Neumann (Avantgarde Pharmaceuticals, Freiburg, Germany) Tailor-made Force Fields - From Crystal Structure Prediction to Drug Discovery Applications 8:20 pm - 8:35 pm Discussion 8:35 pm - 9:15 pm Colin Groom (Cambridge Crystallographic Data Center, Cambridge, UK) Applying the Knowledge Derived from Half a Million Small Molecule Crystal Structures 9:15 pm - 9:30 pm Discussion THURSDAY 7:30 am - 8:30 am Breakfast 9:00 am - 12:30 pm Protein Design Discussion Leader: Karyn O'Neil (Johnson Johnson Ventures, King of Prussia, USA) 9:00 am - 9:15 am Introduction by the discussion leader 9:15 am - 9:55 am Bill deGrado (University of Pennsylvania, Philadelphia, USA) Substrate and Function-Directed Design of Proteins and Peptide Assemblies 9:55 am - 10:10 am Discussion 10:10 am - 10:40 am Coffee Break 10:40 am - 11:20 am Dan Tawfik (Weizmann Institute, Rehovot, Israel) Enzyme Design and Evolution 11:20 am - 11:35 am Discussion 11:35 am - 12:15 pm Brian Kuhlman (University of North Carolina, Chapel Hill, USA) Computational Design of Protein Interfaces and Switches 12:15 pm - 12:30 pm Discussion 12:30 pm Lunch 1:30 pm - 6:00 pm Free Time 6:00 pm Dinner 7:30 pm - 9:30 pm Keynote Session Discussion Leader: Brian Kuhlman (University of North Carolina, Chapel Hill, USA) 7:30 pm - 8:30 pm Jim Wells (UCSF, San Francisco, USA) Turning Enzymes ON with Small Molecules 8:30 pm - 9:00 pm Discussion FRIDAY 7:30 am - 8:30 am Breakfast 9:00 am Departure